Loading clinical trials...

Comparison of Total Tubeless Mini-PCNL Versus Tubeless Mini-PCNL | Clinical Trials | Clareo Health

NOT_YET_RECRUITINGNA

Comparison of Total Tubeless Mini-PCNL Versus Tubeless Mini-PCNL

Comparison of Total Tubeless Mini-PCNL Versus Tubeless Mini-PCNL : A Randomized Controlled Trial

NCT06288022•Mahidol University

Summary

Limited literature has focused on the use of totally tubeless mini-percutaneous nephrolithotomy (Mini-PCNL) for the treatment of large renal stones. This Randomized Controlled trial aims to compare complication and safety of Mini-PCNL between total tubeless and tubeless Mini-PCNL.

Detailed Description

After being informed about study and potential risks, all patient giving written informed consent with undergo a mini-PCNL operation. Patient who meet the eligibility requirements will be randomized in a single-blind manner (patient) in a 1:1 ratio to total tubeless mini-PCNL or tubeless mini-PCNL.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients diagnosed with kidney stones with a size ranging from 20 to 40 millimeters.
•Patients have undergone mini-PCNL, unilateral
•Absence of urinary tract infections before surgery.
•No urological congenital abnormality
•No coagulopathy

Exclusion Criteria

•Presence of residual stones after the surgery, fragments larger than 4 millimeters.
•Patients with a single functioning kidney
•Complicated cases, including:
•1. massive bleeding in the upper tract during surgery
•2. Severe collecting systems injury during surgery
•3. Severe UPJ mucosa swelling considered unsafe by the physician, requiring the placement of a DJ stent or nephostomy tube
•Participants who decline or request withdrawal from the research study.

Locations (1)

Ramathibodi Hospital, Mahidol University

Bangkok, Ratchathewi, Thailand

Key Dates

Start Date

April 1, 2024

Primary Completion Date

April 30, 2026

Completion Date

June 30, 2026

Last Updated

March 7, 2024

Enrollment

130

ESTIMATED participants

Conditions

Surgery-ComplicationsNephrolithiasis Staghorn CalculusSafety Issues

Interventions

total tubeless mini-PCNL

OTHER

tubeless mini-PCNL

OTHER

Contacts

THANAKORN SIRAJARUS

CONTACT

086-599-3259 thanakorn.sjr@gmail.com

Chinnakhet Ketsuwan

CONTACT

086-345-6901 chinnakhet.ket@mahidol.ac.th

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

NCT05991453

Surgery-ComplicationsAnesthesia Complication+6 more

View study

RECRUITING

Tenofovir Alafenamide Switch Therapy in Chronic Hepatitis B

NCT05583006

Patient SatisfactionDrug Adherence+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 7, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Comparison of Total Tubeless Mini-PCNL Versus Tubeless Mini-PCNL

Inclusion Criteria

Exclusion Criteria

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

Tenofovir Alafenamide Switch Therapy in Chronic Hepatitis B

Assessing Pancreatic Fistula Rates After Distal Pancreatectomy Using AEON Endostapler

The STRIVE Before Surgery Trial

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

A Phase 1 Study to Evaluate the Safety/Tolerability, PK/PD of RG002C0106 Injection in Healthy Adults